Strategic Partnership with NHS Confederation
Stock | Beamtree Holdings Ltd (BMT.ASX) |
---|---|
Release Time | 30 May 2025, 9:41 a.m. |
Price Sensitive | Yes |
Beamtree Expands into UK with NHS Confederation Partnership
- 5-year strategic partnership with NHS Confederation
- Membership pricing at £50,000 per hospital trust per year
- Beamtree to invest ~AUD$1.5m over FY25 and FY26 to establish platform
Beamtree Holdings Limited (ASX: BMT), a leader in healthcare analytics and benchmarking across Australia, New Zealand, Canada and the Middle East, is expanding its presence in the United Kingdom through a strategic partnership with the NHS Confederation, which represents approximately 120 NHS Trusts in England. The new Evolve Collaborative with NHS Confederation aims to replicate Beamtree's successful ANZ membership model within England, Wales, and Northern Ireland's NHS hospital sector. This partnership represents a substantial commitment to the UK market--a cornerstone of Beamtree's growth strategy--and provides valuable frontline insights into member hospitals' challenges. Key terms of the partnership include a 5-year contract term with a 5-year extension option, membership pricing of £50,000 per annum for each hospital trust, and Beamtree's expected investment of ~AUD$1.5m over FY25 and FY26 to establish the platform in the UK. The partnership also includes provisions for either party to terminate if certain membership thresholds are not met. The Evolve platform is expected to be launched by the end of 2025 with subscription revenue commencing in early 2026.
Beamtree expects to invest approximately AUD$1.5m over FY25 and FY26 to establish the Evolve platform in the UK market.
The partnership with the NHS Confederation represents a substantial commitment to the UK market, which is a cornerstone of Beamtree's growth strategy. The Evolve Collaborative aims to replicate Beamtree's successful ANZ membership model within the NHS hospital sector in England, Wales, and Northern Ireland.